USE OF E-CADHERIN AND VIMENTIN FOR SELECTION OF TREATMENT RESPONSIVE PATIENTS

摘要

Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.